Evaluation of the Health Promotion Program for the Elderly in Chiba Prefecture (Hoi-Dai Health Program) von Hosoyamada, Yasue, Higashimoto, Yasuyuki, Kawano, Kimiko, Ebihara, Yasuyo, Aso, Nami, Okada, Akiko, Minemura, Takao, Shimada, Mieko, Asaga, Tamiyo, Asou, Tomoko, Suzuka, Yuko, Ogata, Satoshi, Takeuchi, Yahiko, Edo, Masahiro, Okamura, Tarou, Watanabe, Tomoko

Volltext

千葉県の高齢者のための健康づくりプログラム（ほい大健康プログラム）に関する評価 von 細山田, 康恵, 東本, 恭幸, 河野, 公子, 海老原, 泰代, 阿曽, 菜美, 岡田, 亜紀子, 峰村, 貴央, 島田, 美恵子, 麻賀, 多美代, 麻賀, 智子, 鈴鹿, 祐子, 雄賀多, 聡, 竹内, 弥彦, 江戸, 優裕, 岡村, 太郎, 渡邊, 智子

Volltext

Potential impact of the COVID-19 pandemic on japanese patients with eating disorders -a cross-sectional study von Takakura, Shu, Toda, Kenta, Yamashita, Makoto, Kitajima, Tomoko, Suematsu, Takafumi, Yokoyama, Hiroaki, Asou, Chie Suzuyama, Hata, Tomokazu, Sudo, Nobuyuki

Volltext

A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia von Iida, Hiroatsu, Imada, Kazunori, Ueda, Yasunori, Kubo, Kohmei, Yokota, Akira, Ito, Yoshikazu, Kiguchi, Toru, Hata, Tomoko, Nawa, Yuichiro, Ikezoe, Takayuki, Uchida, Toshiki, Morita, Yasuyoshi, Kawashima, Ichiro, Chiba, Masahiro, Morimoto, Kensaku, Hirooka, Shihomi, Miyazaki, Yasushi, Ohno, Ryuzo, Naoe, Tomoki

Volltext

IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation von Yamaguchi, Shunichiro, Iwanaga, Eisaku, Tokunaga, Kenji, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Mitsuya, Hiroaki, Asou, Norio

Volltext

Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes von Kawai, Nobutaka, Matsuda, Akira, Jinnai, Itsuro, Ichimura, Takaya, Kayano, Hidekazu, Okamura, Daisuke, Ishikawa, Maho, Maeda, Tomoya, Hata, Tomoko, Miyazaki, Yasushi, Asou, Norio, Bessho, Masami, Tomonaga, Masao

Volltext

Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study von Ogura, Michinori, Prof, Imaizumi, Yoshitaka, MD, Uike, Naokuni, MD, Asou, Norio, MD, Utsunomiya, Atae, MD, Uchida, Toshiki, MD, Aoki, Tomohiro, MD, Tsukasaki, Kunihiro, MD, Taguchi, Jun, MD, Choi, Ilseung, MD, Maruyama, Dai, MD, Nosaka, Kisato, MD, Chen, Nianhang, PhD, Midorikawa, Shuichi, PhD, Ohtsu, Tomoko, MD, Tobinai, Kensei, MD

Volltext

High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia von Tokunaga, Kenji, Yamaguchi, Shunichiro, Iwanaga, Eisaku, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Mitsuya, Hiroaki, Asou, Norio

Volltext

Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia von Asou, Norio, Iwanaga, Eisaku, Nanri, Tomoko, Mitsuya, Hiroaki

Volltext

Mutation in the RNA binding protein TIS11D/ZFP36L2 is associated with the pathogenesis of acute leukemia von IWANAGA, Eisaku, NANRI, Tomoko, MITSUYA, Hiroaki, ASOU, Norio

Volltext

A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia von Iwanaga, Eisaku, Nanri, Tomoko, Matsuno, Naofumi, Kawakita, Toshiro, Mitsuya, Hiroaki, Asou, Norio

Volltext

Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia von Kamijo, Rena, Itonaga, Hidehiro, Kihara, Rika, Nagata, Yasunobu, Hata, Tomoko, Asou, Norio, Ohtake, Shigeki, Shiraishi, Yuichi, Chiba, Kenichi, Tanaka, Hiroko, Miyano, Satoru, Ogawa, Seishi, Naoe, Tomoki, Kiyoi, Hitoshi, Miyazaki, Yasushi

Volltext

A family harboring a germ-line N-terminal C/EBPα mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPα mutation von Nanri, Tomoko, Uike, Naokuni, Kawakita, Toshiro, Iwanaga, Eisaku, Mitsuya, Hiroaki, Asou, Norio

Volltext

IDH1and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation von Yamaguchi, Shunichiro, Iwanaga, Eisaku, Tokunaga, Kenji, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Okuno, Yutaka, Mitsuya, Hiroaki, Asou, Norio

Volltext

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation von Yamaguchi, Shunichiro, Iwanaga, Eisaku, Tokunaga, Kenji, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Okuno, Yutaka, Mitsuya, Hiroaki, Asou, Norio

Volltext

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia von Yamaguchi, Shunichiro, Tokunaga, Kenji, Iwanaga, Eisaku, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Mitsuya, Hiroaki, Asou, Norio

Volltext

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia von Tokunaga, Kenji, Yamaguchi, Shunichiro, Iwanaga, Eisaku, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Hiroaki, Mitsuya, Asou, Norio

Volltext

IDH 1 and IDH 2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM 1 mutation von Yamaguchi, Shunichiro, Iwanaga, Eisaku, Tokunaga, Kenji, Nanri, Tomoko, Shimomura, Taizo, Suzushima, Hitoshi, Mitsuya, Hiroaki, Asou, Norio

Volltext

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia von Yamaguchi, Shunichro, Iwanaga, Eisaku, Tokunaga, Kenji, Nanri, Tomoko, Suzushima, Hitoshi, Shimomura, Taizo, Mitsuya, Hiroaki, Asou, Norio

Volltext

Micafungin-induced immune hemolysis attacks von Nanri, Tomoko, Iwanaga, Eisaku, Fujie, Satomi, Yamada, Yasuhiro, Horikawa, Kentaro, Mitsuya, Hiroaki, Asou, Norio

Volltext